Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorder
Okhuijsen-Pfeifer, C., van der Horst, M.Z., Bousman, C.A., Lin, B., van Eijk, K.R., Ripke, S., Ayhan, Y., Jeger-Land, E.,
De Koning, M.B., GROUP investigators & Luykx, J. (et al.)
Verschenen in Translational Psychiatry, 12, 145 (2022)
Oxidative stress in psychosis: a new target for intervention?
Hagen, J., Sutterland, A.L., Wezenberg, B.N., Tan, H.L. &
De Haan, L.Verschenen in Tijdschrift Voor Psychiatrie, 64 (1), 38-42 (2022)
De ondervertegenwoordiging van complexe patiëntengroepen in wetenschappelijk onderzoek: ethische overwegingen
De Koning, M.B.,
Burger, T.,
Van Eck, R.,
Kikkert, M.J.,
De Haan, L. &
Vellinga, A.Verschenen in Tijdschrift voor Psychiatrie, 63, 731-736 (2021)
Individualized prediction of three- and six-year outcomes of psychosis in a longitudinal multicenter study: a machine learning approach
de Nijs, J.,
Burger, T., Janssen, R.J., Mostafa Kia, S., van Opstal, D.P.J.,
De Koning, M.B.,
De Haan, L., GROUP Investigators, Cahn, W. & Schnack, H.G.
Verschenen in Nature: Schizophrenia (2021)
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial
Begemann, M.J.H., Thompson, I.A., Veling, W., Gangadin, S.S., Geraets, C.N.W., van 't Hag, E., Müller-Kuperus, S.J., Oomen, P.P., Voppel, A.E., van der Gaag, M.,
Kikkert, M.J., van Os, J., HAMLETT Group,
De Haan, L. & Sommer, I.E.C.
Verschenen in Trials, 21, 147 (2021)
Tapering antipsychotic medication: practical considerations
Horowitz, A., Moncrieff, J.,
De Haan, L., Bogers, J.P.A.M., Gangadin, S.S.,
Kikkert, M.J., Veling, W. & Sommer, I.E.C.
Verschenen in Psychological Medicine, 52 (1) (2021)
Skin autofluorescence of advanced glycation end products and mortality in affective disorders in the lifelines cohort study: A mediation analysis
Hagen, J., Sutterland, A.L., Liefers, T.,
Schirmbeck, F., Cohn, D.M., Lok, A., Tan, H.L.O., Zwinderman, A.H. &
De Haan, L.Verschenen in Journal of Affective Disorders, 282, 1082-1089 (2021)
Medication strategies in first episode psychosis patients: A survey among psychiatrists
Kikkert, M.J., Veling, W.,
De Haan, L., Begemann, M.J.H.,
De Koning, M.B., HAMLETT and OPHELIA Consortium & Sommer, I.E.
Verschenen in Early Intervention in Psychiatry, 1-8 (2021)
Ethnic discrimination and depressed mood: The role of autonomic regulation
Hagen, J., Sutterland, A.L., Collard, D., de Jonge, C.D.E., van Zuiden, M., Zantvoord, J.B.,
De Haan, L., Lok, A. & et al.
Verschenen in Journal of Psychiatric Research, 144, 110-117 (2021)
A comparison of depressive symptom profiles between current major depressive disorder and schizophrenia spectrum disorder
Lange, S.M.M., Schirmbeck, F., Stek, M.L., Murk Jansen, Y.R., van Rooijen, G.,
De Haan, L., Penninx, B.W.J.H. & Rhebergen, D.
Verschenen in Journal of Psychiatric Research, Volume 135, 143-151 (2021)
An old but still burning problem: Inter-rater reliability in clinical trials with antidepressant medication
Berendsen, S., Verdegaal, L.M.A., van Tricht, M.J.,
Blankers, M.,
Van, H. &
De Haan, L.Verschenen in Journal of Affective Disorders, Volume 276, 748-751 (2020)
Association between skin autofluorescence of advanced glycation end products and affective disorders in the lifelines cohort study
Hagen, J., Sutterland, A.L., da Fonseca Pereira de Sousa, P.A.L.,
Schirmbeck, F., Cohn, D.M., Lok, A., Tan, H.L., Zwinderman, A.H. &
De Haan, L.Verschenen in Journal of Affective Disorders, 275, 230-237 (2020)
Association between cognitive phenotype in unaffected siblings and prospective 3- and 6-year clinical outcome in their proband affected by psychosis
Burger, T.,
Schirmbeck, F., Vermeulen, J.M., Quee, P.J.,
De Koning, M.B., Bruggeman, R. &
De Haan, L.Verschenen in Psychological Medicine, 1-11 (2020)
Skin autofluorescence of advanced glycation end products and course of affective disorders in the lifelines cohort study, a prospective investigation
Hagen, J., Sutterland, A.L.,
Schirmbeck, F., Cohn, D.M., Lok, A., Tan, H.L.O., Zwinderman, A.H. &
De Haan, L.Verschenen in Journal of Affective Disorders, 276, 424-432 (2020)
Staging and profiling for schizophrenia spectrum disorders: Inter-rater reliability after a short training course
Berendsen, S., van der Paardt, J.W.,
Van, H., van Bruggen, M., Nusselder, H., Jalink, M., de Peuter, O.R.,
Peen, J., van Tricht, M.J. &
De Haan, L.Verschenen in Progress in Neuro-Psychopharmacology and Biological Psychiatry, Volume 99, 1-6 (2020)
Stressful experiences affect the course of co-occurring obsessive-compulsive and psychotic symptoms: A focus on within-subject processes
Schirmbeck, F., Konijn, M., Hoetjes, V., Vermeulen, J.M.D., Zink, M.,
Dekker, J.J.M. &
De Haan, L.Verschenen in Schizophrenia Research, 216, 69-76 (2020)
Exploration of symptom dimensions and duration of untreated psychosis within a staging model of schizophrenia spectrum disorders
Berendsen, S.,
Van, H., van der Paardt, J.W., de Peuter, O.R., van Bruggen, M., Nusselder, H., Jalink, M.,
Peen, J.,
Dekker, J.J.M. &
De Haan, L.Verschenen in Early Intervention in Psychiatry, Volume 15, issue 3, 669-675 (2020)
The bumpy road to achieve reliability of clinical profile characteristics in psychosis and related disorders
Berendsen, S., van Tricht, M.J., Tedja, A.,
Burger, T.,
De Koning, M.B. &
De Haan, L.Verschenen in International Journal of Methods in Psychiatric Research, Volume 30, Issue 2, 1-8 (2020)
Pre-training inter-rater reliability of clinical instruments in an international psychosis research project
Berendsen, S., Kapitein, P.,
Schirmbeck, F., van Tricht, M.J., Mcguire, P., Morgen, C.,
De Haan, L. & et al.
Verschenen in Schizophrenia Research, Volume 230, 104-107 (2020)
